[Behavior of the night decrease of arterial pressure after suppression controlled of the antihypertensive medication]

F Villalba Alcalá1, A Espino Montoro, C Alvarez Lacayo

  • 1Doctor en Medicina. Médico de Familia. Servicio de Cuidados Críticos y Urgencias del Hospital de La Merced. Osuna. Sevilla. España. franvillalba81@hotmail.com

Atencion Primaria
|April 12, 2003
PubMed

Insights

Discontinuing antihypertensive medication in well-controlled hypertension did not alter the percentage of patients who are "dippers" (showing a normal night-time blood pressure decrease). This suggests medication withdrawal does not significantly impact this cardiovascular risk indicator.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Clinical Research

Background:

  • Patients with hypertension lacking a normal night-time blood pressure decrease (non-dippers) exhibit increased target organ damage.
  • Ambulatory blood pressure monitoring (ABPM) is crucial for assessing blood pressure patterns.

Purpose of the Study:

  • To analyze the prevalence of the "dipper" status in patients with controlled Grade 1 or 2 hypertension after discontinuing antihypertensive medication.
  • To evaluate changes in blood pressure patterns, specifically the "dipper" phenomenon, following medication withdrawal.

Main Methods:

  • An observational, descriptive study involving 70 essential hypertensive patients with controlled blood pressure.
  • ABPM was conducted in two phases: before and 4 weeks after suspending antihypertensive medication, with diurnal and nocturnal readings.

Main Results:

  • 18 patients (26%) could not complete the study due to unacceptable blood pressure after medication withdrawal.
  • 83% of patients remained "dippers" after medication suppression, with no significant gender-based differences in night-time blood pressure reduction.
  • A majority of patients (75%) maintained their "dipper" or "non-dipper" status throughout the study.

Conclusions:

  • Withdrawing antihypertensive medication in well-controlled Grade 1 or 2 hypertensive patients does not alter the proportion of individuals exhibiting normal night-time blood pressure decreases.
  • The "dipper" status, a marker of cardiovascular risk, appears stable in this patient group upon short-term medication cessation.
Abstract

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...